长段Barrett食管经酸抑制-十二指肠转流术18年结果:优于Nissen胃底折叠术?
这项前瞻性研究纳入127例长段及超长段Barrett食管患者,行选择性迷走神经切断、胃底折叠、部分胃切除加Roux-en-Y重建的酸抑制-十二指肠转流术(AS-DD)。平均随访18年,81%完成随访,病理酸反流消除91%、十二指肠反流消除100%,长段Barrett食管肠化生消退38%,两组各2例进展为食管腺癌。
要点
- AS-DD可永久消除食管病理性反流,十二指肠反流消除率达100%。
- 长段Barrett食管肠化生消退38%,低级别异型增生80%消退为肠化生。
- 进展为高级别异型增生/食管腺癌风险较药物治疗低,长段降低8倍、超长段降低2.2倍。
核心结论
- AS-DD可永久消除食管病理性反流,长段Barrett食管进展为高级别异型增生/食管腺癌的风险较药物治疗降低8倍,超长段降低2.2倍。
研究设计与样本
- 前瞻性研究纳入127例长段及超长段Barrett食管患者,行选择性迷走神经切断、胃底折叠、部分胃切除加Roux-en-Y重建,随访完成率81%、平均18年。
主要发现
- Visick I-II评分在长段Barrett食管为88%、超长段为65%(P < 0.01)。
- 糜烂性食管炎和食管消化性溃疡显著愈合,狭窄71%缓解。
- 长段Barrett食管肠化生消退38%,两组各2例平均15年进展为食管腺癌。
- 病理性酸反流消除91%,十二指肠反流消除100%。
- 低级别异型增生80%消退为肠化生。
关键数值与推荐
- 长段Barrett食管进展为高级别异型增生/食管腺癌风险较药物治疗降低8倍,超长段降低2.2倍。
临床怎么用
- AS-DD可作为长段及超长段Barrett食管控制混合反流、影响肠化生行为并延缓食管腺癌进展的手术选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine late results of AS-DD procedure in long-segment (LSBE) and extralong-segment BE (ELSBE) using subjective and objective measurements to ascertain the histological impact over intestinal metaplasia (IM) and progression to EAC. SUMMARY OF BACKGROUND DATA: Barrett esophagus (BE) is a known precursor of esophageal adenocarcinoma (EAC), and Nissen fundoplication has proven to be unable to stop mixed reflux among them. Our group proposed a surgical procedure that handles pathophysiological changes responsible for BE. METHODS: This prospective study included 127 LSBE and ELSBE subjects submitted to clinical and functional analyses. They were presented to selective vagotomy, fundoplication, partial gastrectomy with Roux-en-Y reconstruction. The changes in IM were determined in both groups. RESULTS: Follow-up was completed at a mean of 18 years in 81% of the cases. Visick I-II scores were seen in 88% of LSBE and 65% in ELSBE ( P < 0.01). There was significant healing of erosive esophagitis and esophageal peptic ulcers, and strictures were resolved in 71%. There was 38% of IM regression in LSBE. Two cases in each group progressed to EAC at a mean of 15 years. Pathologic acid reflux was abolished in 91% and duodenal in 100%. There was a regression of low-grade dysplasia to IM in 80%. CONCLUSIONS: AS-DD permanently eliminates pathologic refluxate to the esophagus. The progression to HGD/EAC is lower compared to medical treatment, with an 8-fold reduction in LSBE and 2.2-fold in ELSBE. AS-DD seems to influence IM behaviors, and it is a tool that could reduce and delay progression to EAC.
引用
- Csendes A, Orellana O, Figueroa M, et al. Long-term (18 Years) Results of Patients With Long-segment Barrett Esophagus Submitted to Acid Suppression-duodenal Diversion Operation: Better Than Nissen Fundoplication? Ann Surg. 2023. PMID: 33470631. doi:10.1097/SLA.0000000000004760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。